GlassScriptPhysician profile
Chad O Patterson
NPI 1023200920
$8,644.45
in general payments reported to CMS, 2019-2025
19 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $142 · 2021: $29.31 · 2022: $127 · 2023: $62.50 · 2024: $7,837 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $1,638 · Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $1,638.22 |
| Food and Beverage | $1,009.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,762.78 | 2024 | |
| Tesaro, INC. | $137.19 | 2019 | |
| Glaxosmithkline, LLC. | $127.63 | 2020 | |
| Ethicon US, LLC | $118.44 | 2019-2023 | Mega Soft |
| Innocoll Pharmaceuticals Limited | $104.75 | 2021-2022 | |
| Polynovo North America LLC | $63.91 | 2024-2025 | Novosorb Btm |
| Abbvie INC. | $42.47 | 2025 | |
| Solventum Corporation | $34.82 | 2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Heron Therapeutics, INC. | $30.32 | 2021-2022 | |
| Madrigal Pharmaceuticals | $28.67 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $28.19 | 2025 | Tremfya |
| Reprise Biomedical, INC. | $28.15 | 2024-2025 | Miro3d |
| Depuy Synthes Sales INC. | $27.12 | 2024 | Na, Xcm Biologic Tissue Matrix |
| Ironshore Pharmaceuticals INC. | $26.96 | 2019 | |
| Smith+Nephew, INC. | $21.65 | 2025 | Collagenase Santyl |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $16.36 | 2025 | |
| Aimmune Therapeutics, INC. | $16.33 | 2025 | Vowst |
| Ardelyx, INC. | $14.79 | 2025 | Ibsrela |
| Tela Bio, INC. | $13.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.